Get the Stockscreener App
352.82
0.93%
3.26
After Hours:
352.82
Insulet Corporation stock is traded at $352.82, with a volume of 656.70K.
It is up +0.93% in the last 24 hours and up +14.89% over the past month.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
See More
Previous Close:
$349.56
Open:
$349.27
24h Volume:
656.70K
Relative Volume:
0.96
Market Cap:
$24.84B
Revenue:
$2.36B
Net Income/Loss:
$236.10M
P/E Ratio:
107.24
EPS:
3.29
Net Cash Flow:
$382.50M
1W Performance:
+2.29%
1M Performance:
+14.89%
6M Performance:
+40.11%
1Y Performance:
+61.01%
1-Day Range:
$347.31
$353.50
1-Week Range:
$339.00
$353.50
52-Week Range:
$217.82
$353.50
Insulet Corporation Stock (PODD) Company Profile
Name
Insulet Corporation
Sector
Industry
Phone
978-600-7000
Address
100 NAGOG PARK, ACTON, MA
Compare PODD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
352.82 | 24.61B | 2.36B | 236.10M | 382.50M | 3.29 |
|
ABT
Abbott Laboratories
|
131.95 | 230.09B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
108.09 | 160.24B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
392.76 | 150.29B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.07 | 119.28B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
79.80 | 47.09B | 5.69B | 1.41B | 577.90M | 6.95 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Resumed | Oppenheimer | Outperform |
| Jun-16-25 | Initiated | Truist | Buy |
| May-30-25 | Initiated | Goldman | Buy |
| May-13-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-29-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-06-25 | Initiated | RBC Capital Mkts | Outperform |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-07-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-02-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-21-23 | Upgrade | Citigroup | Neutral → Buy |
| Aug-21-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-01-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-19-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Jul-28-20 | Initiated | Wells Fargo | Overweight |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-03-20 | Initiated | BofA/Merrill | Neutral |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-10-19 | Initiated | CFRA | Sell |
| Oct-23-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-14-19 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-04-19 | Downgrade | UBS | Buy → Neutral |
| Oct-03-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-06-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-10-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-06-19 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Feb-22-18 | Reiterated | Barclays | Overweight |
| Jan-08-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-03-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-15-17 | Initiated | Barclays | Overweight |
View All
Insulet Corporation Stock (PODD) Latest News
Top Executives at Insulet Make Significant Stock Sales! - TipRanks
Insulet at Baird Global Healthcare: Strategic Growth and Innovation - Investing.com
Transcript : Insulet Corporation Presents at Baird Global Healthcare Conference 2025, Sep-09-2025 12 - MarketScreener
Insulet stock hits all-time high at 350.92 USD - Investing.com
Insulet Stock: Analyst Estimates & Ratings - MSN
US medical device maker plans Middle East expansion - Arabian Gulf Business Insight | AGBI
Insulet Corporation $PODD Holdings Raised by Parkman Healthcare Partners LLC - MarketBeat
Oppenheimer Adjusts Insulet Price Target to $365 From $324, Maintains Outperform Rating - MarketScreener
Oppenheimer initiates coverage on Insulet stock with Outperform rating - Investing.com
Oppenheimer Starts Insulet Corporation (PODD) at Outperform - StreetInsider
What’s Insulet Corporation’s historical returnMarket Weekly Review & Daily Profit Maximizing Trade Tips - خودرو بانک
Market Participants Recognise Insulet Corporation's (NASDAQ:PODD) Revenues Pushing Shares 26% Higher - simplywall.st
Can Insulet Corporation keep up with sector leadersWeekly Stock Recap & Weekly High Return Stock Opportunities - خودرو بانک
Is Insulet Corporation subject to activist investor interest2025 Volatility Report & Fast Moving Trade Plans - خودرو بانک
Short interest data insights for Insulet CorporationTake Profit & Technical Pattern Based Buy Signals - Newser
Can Insulet Corporation stock outperform in a bear marketLayoff News & Community Consensus Trade Alerts - خودرو بانک
Is Insulet Corporation a top pick in the sectorQuarterly Trade Summary & Free Growth Oriented Trading Recommendations - خودرو بانک
What is the long term forecast for Insulet Corporation stockMarket Activity Report & Safe Entry Zone Identification - خودرو بانک
What high frequency data says about Insulet CorporationBond Market & Long Hold Capital Preservation Tips - Newser
Candlestick signals on Insulet Corporation stock today2025 Price Targets & High Return Stock Watch Alerts - Newser
Using data tools to time your Insulet Corporation exit2025 EndofYear Setup & Consistent Income Trade Recommendations - Newser
How high can Insulet Corporation stock goRate Hike & High Yield Equity Trading Tips - Newser
Insulet at Wells Fargo Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa
Insulet at Wells Fargo Conference: Strategic Growth and Innovation - Investing.com India
What’s the profit margin of Insulet Corporation2025 Sector Review & Daily Stock Trend Reports - خودرو بانک
Insulet Corporation's Strategic Position in the Evolving Diabetes Management Market - AInvest
How to track smart money flows in Insulet CorporationJuly 2025 PostEarnings & Long Hold Capital Preservation Tips - Newser
What the charts say about Insulet Corporation todayJuly 2025 Review & Daily Chart Pattern Signals - Newser
Insulet Corporation recovery potential after sell off2025 Biggest Moves & Low Risk High Win Rate Picks - Newser
Smart tools for monitoring Insulet Corporation’s price actionMarket Volume Report & Free High Accuracy Swing Entry Alerts - Newser
Insulet Corporation Facing Inflection Point in Trend AnalysisQuarterly Investment Review & AI Driven Stock Price Forecasts - beatles.ru
Tools to monitor Insulet Corporation recovery probabilityJuly 2025 Reactions & Capital Efficient Trading Techniques - Newser
What MACD and RSI say about Insulet CorporationJuly 2025 Update & Safe Entry Zone Identification - Newser
Analyzing Insulet Corporation with multi timeframe chartsJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - Newser
Multi factor analysis applied to Insulet Corporation2025 Support & Resistance & Real-Time Stock Movement Alerts - Newser
Is Insulet Corporation trending in predictive chart models2025 Sector Review & Accurate Entry/Exit Alerts - Newser
Can Insulet Corporation reach all time highs this yearWeekly Gains Report & Short-Term Trading Opportunity Alerts - خودرو بانک
Does Insulet Corporation have pricing powerRisk Management & Low Risk Growth Stock Ideas - khodrobank.com
Intraday pattern recognizer results for Insulet CorporationJuly 2025 Opening Moves & Low Risk Investment Opportunities - Newser
Insulet Corporation stock daily chart insightsEarnings Beat & Free Low Drawdown Momentum Trade Ideas - Newser
Analyzing net buyer seller activity in Insulet CorporationJuly 2025 Short Interest & AI Powered Market Entry Strategies - Newser
Using flow based indicators on Insulet Corporation2025 Volatility Report & Daily Growth Stock Investment Tips - Newser
Can Insulet Corporation deliver consistent EPS growthJuly 2025 Selloffs & Expert Curated Trade Setup Alerts - خودرو بانک
How to escape a deep drawdown in Insulet CorporationWeekly Loss Report & Reliable Intraday Trade Plans - Newser
How to integrate Insulet Corporation into portfolio analysis toolsMarket Performance Report & Expert Approved Momentum Trade Ideas - Newser
Can volume confirm reversal in Insulet CorporationAnalyst Upgrade & Safe Entry Zone Tips - Newser
How to build a custom watchlist for Insulet CorporationPortfolio Return Report & Low Volatility Stock Suggestions - Newser
Published on: 2025-09-03 00:46:23 - Newser
How to recover losses in Insulet Corporation stockQuarterly Portfolio Report & Weekly High Conviction Ideas - Newser
Is Insulet Corporation’s growth already priced in2025 Top Decliners & AI Driven Stock Movement Reports - خودرو بانک
Technical signs of recovery in Insulet Corporation2025 Price Action Summary & Free Long-Term Investment Growth Plans - Newser
Insulet Corporation Stock (PODD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.03%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):